its one thing to invest in biotech. but your valuations are way off. most preclinical stage bios are not valued at anything $10m or under; with some initial invitro or invivo data depending on indication at minimum its $20M. If you want to really help bios and invest in quality companies then you need to change your valuation perception especially for biotech.
YC is great...Thanks Jared Friedman and Surbhi Sarna for the info..
its one thing to invest in biotech. but your valuations are way off. most preclinical stage bios are not valued at anything $10m or under; with some initial invitro or invivo data depending on indication at minimum its $20M. If you want to really help bios and invest in quality companies then you need to change your valuation perception especially for biotech.